$21.74
At close: Apr 11, 4:15 PM EDT
$21.40
-0.34-1.56%
Pre-Market: Apr 4, 4:29 PM EDT
As of Feb 28, 2025
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)
Ticker | Name | Share % | |
---|---|---|---|
LLY | Eli Lilly & Co. | 18.09% | |
CO | Novo Nordisk A/S ADR | 15.16% | |
JP | Chugai Pharmaceutical Co Ltd | 4.63% | |
AMGN | Amgen Inc. | 4.31% | |
HK | Innovent Biologics Inc | 3.84% | |
SM | Roche Holding Ag | 5.84% | |
LN | Developed Markets Astrazeneca Plc Sponsored Adr | 4.88% | |
KR | Hanmi Pharm Co Ltd | 2.71% | |
SH | Innovent Biologics Inc | 3.92% | |
PFE | Pfizer, Inc. | 3.54% |
The OZEM ETF is currently trading at $21.74, which represents a 0.00% change. Over the past 52 weeks, the ETF has traded as high as $29.21 and as low as $20.01.
The expense ratio of OZEM is 0.59%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for OZEM is 31.46M. This represents the total market value of the assets managed by the ETF.
OZEM follows a Large Cap Blend investment style.
The top holdings of OZEM include: LLY (18.09%), CO (15.16%), JP (4.63%), AMGN (4.31%), HK (3.84%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for OZEM is currently not available.